Ronald A. Conlon

Ronald A. Conlon is a Professor in the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine. He serves as Director of the Case Transgenic and Targeting Facility and is a Member of the Cancer Genomics and Epigenomics Program at the Case Comprehensive Cancer Center.

Dr. Conlon received his education at the University of Western Ontario, McGill University, and The University of Texas at Austin. He completed postdoctoral training in Janet Rossant's laboratory in Toronto, where he was introduced to embryonic stem cells and gene targeting.

As a developmental biologist, Dr. Conlon's research focuses on using genetics to probe fundamental biological mechanisms. His laboratory has developed innovative genetic techniques including methods for creating large multi-gene deletions and transgenics with intact human genes. His work exploits CRISPR/Cas9 gene editing to develop novel reporters and humanized alleles. Current research emphasizes translating gene-corrective techniques into therapies for genetic diseases, particularly cystic fibrosis. His specific interests include targeted mutagenesis, gene control of morphogenesis and pattern formation, and genome mapping in mice.

Analysis of Dr. Conlon's recent publications reveals a strong focus on gene editing applications for disease treatment, particularly cystic fibrosis and retinal disorders. His work spans basic research on developmental mechanisms to translational applications, with increasing emphasis on therapeutic development in recent years. The publications demonstrate interdisciplinary collaboration across genetics, molecular biology, and clinical research.

Dr. Conlon leads the Case Transgenic and Targeting Facility, which provides critical resources for genetic engineering research. His work on the CWRU Therapeutics Pipeline for Genetic Disease is advancing gene-corrective therapeutics toward clinical applications. While specific grant information isn't detailed in the provided text, his research program appears substantial given the volume and quality of recent publications.

Dr. Conlon's laboratory is actively involved in developing new genetic techniques and applying them to understand and treat genetic disorders. His work bridges fundamental developmental biology with cutting-edge therapeutic approaches, positioning his research at the forefront of genetic medicine.